Welcome to kongre.net
Speaker
Executive Director & Head of Liver Disease Research & Drug Discovery, GI-Ddu, Takeda Pharmaceutical
Bernard Allan, Executive Director & Head of Liver Disease Research & Drug Discovery, GI-Ddu at Takeda Pharmaceutical, is speaking at 10th Antifibrotic Drug Development Summit 2026 (Boston, United States of America, 1–3 Dec 2026) in the session “A Translational Pharmacology Framework to Drive Antifibrotic Programs”.
1–3 Dec 2026Boston, United States of America
Director, Madrigal Pharmaceuticals
Principal Scientist II, Novartis AG
CMO, Mediar Therapeutics
Co-Founder & Chief Executive Officer, Refoxy Pharmaceuticals
Head of Translational Sciences, Fibrocor Therapeutics
Medical Director, Takeda Pharmaceutical
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Bernard Allan, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].